Biosynthesis of the galactan component of the mycobacterial cell wall

被引:98
作者
Mikusová, K [1 ]
Yagi, T [1 ]
Stern, R [1 ]
McNeil, MR [1 ]
Besra, GS [1 ]
Crick, DC [1 ]
Brennan, PJ [1 ]
机构
[1] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA
关键词
D O I
10.1074/jbc.M006875200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structural core of the cell walls of Mycobacterium spp. consists of peptidoglycan bound by a Linker unit (-alpha -L-Rhap-(1-->3)-D-GlcNAc-P-) to a galactofuran, which in turn is attached to arabinofuran and mycolic acids. The sequence of reactions leading to the biogenesis of this complex starts with the formation of the Linker unit on a polyprenyl-P to produce polyprenyl-P-P-GlcNAc-Rha (Mikusova, K., Mikus, M., Besra, G. S., Hancock, I., and Brennan, P. J. (1996) J. Biol. Chem. 271, 7820-7828), me now establish that formation of the galactofuran takes place on this intermediate with UDP-Galf as the Galf donor presented in the form of UDP-Galp and UDP-Galp mutase (the glf gene product) and is catalyzed by galactofuranosyl transferases, one of which, the Mycobacterium tuberculosis H37Rv3808c gene product, has been identified. Evidence is also presented for the growth of the arabinofuran on this polyprenyl-P-P-linker unit-galactan intermediate catalyzed by unidentified arabinosyl transferases, with decaprenyl-P-Araf or B-P-ribosyl-PP as the Araf donor, The product of these steps, the lipid-linked-LU-galaetan-arabinan has been partially characterized in terms of its heterogeneity, size, and composition. Biosynthesis of the major components of mycobacterial cell walls is proving to be extremely complex. However, partial definition of arabinogalactan synthesis, the site of action of several major anti-tuberculosis drugs, facilitates the present day thrust for new drugs to counteract multiple drug-resistant tuberculosis.
引用
收藏
页码:33890 / 33897
页数:8
相关论文
共 34 条
[2]   The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol [J].
Belanger, AE ;
Besra, GS ;
Ford, ME ;
Mikusova, K ;
Belisle, JT ;
Brennan, PJ ;
Inamine, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11919-11924
[3]   Biosynthesis of mycobacterial lipoarabinomannan [J].
Besra, GS ;
Morehouse, CB ;
Rittner, CM ;
Waechter, CJ ;
Brennan, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (29) :18460-18466
[4]   THE ENVELOPE OF MYCOBACTERIA [J].
BRENNAN, PJ ;
NIKAIDO, H .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :29-63
[5]  
Breton C, 1998, J BIOCHEM, V123, P1000
[6]   A SIMPLE AND RAPID METHOD FOR THE PERMETHYLATION OF CARBOHYDRATES [J].
CIUCANU, I ;
KEREK, F .
CARBOHYDRATE RESEARCH, 1984, 131 (02) :209-217
[7]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[8]  
Crick D., 2000, Curr Opin Anti-infect Investing Drugs, V2, P154
[9]  
DAFFE M, 1990, J BIOL CHEM, V265, P6734
[10]  
Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131